Literature DB >> 27612297

Therapeutic drug monitoring in the era of precision medicine: opportunities!

Serge Cremers1, Nishan Guha2, Brian Shine2.   

Abstract

Mesh：

Year:  2016        PMID： 27612297      PMCID： PMC5137816          DOI： 10.1111/bcp.13047

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  23 in total

1.  Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.

Authors:  Jennifer H Martin; Elizabeth Phillips; David Thomas; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2015-11       Impact factor: 4.335

2.  Safe and effective variability-a criterion for dose individualization.

Authors:  Nicholas H G Holford; Thierry Buclin
Journal:  Ther Drug Monit       Date:  2012-10       Impact factor: 3.681

3.  Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia.

Authors:  Kazuaki Taguchi; Masahiko Kouroki; Takafumi Ohmura; Hirofumi Jono; Fumio Endo; Hideyuki Saito
Journal:  Pediatr Int       Date:  2014-08       Impact factor: 1.524

4.  Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers.

Authors:  Patricia M LoRusso; Smitha S Krishnamurthi; John J Rinehart; Lisle M Nabell; Lisa Malburg; Paul B Chapman; Samuel E DePrimo; Steven Bentivegna; Keith D Wilner; Weiwei Tan; Alejandro D Ricart
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  Evidence based drug dosing and pharmacotherapeutic recommendations per genotype.

Authors:  Vera H M Deneer; Ron H N van Schaik
Journal:  Methods Mol Biol       Date:  2013

6.  Validation of a pediatric population pharmacokinetic model for vancomycin.

Authors:  Andrea Hahn; Robert W Frenck; Yuanshu Zou; Alexander A Vinks
Journal:  Ther Drug Monit       Date:  2015-06       Impact factor: 3.681

7.  Therapeutic drug monitoring in cancer--are we missing a trick?

Authors:  Christophe Bardin; Gareth Veal; Angelo Paci; Etienne Chatelut; Alain Astier; Dominique Levêque; Nicolas Widmer; Jos Beijnen
Journal:  Eur J Cancer       Date:  2014-05-27       Impact factor: 9.162

Review 8.  The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

Authors:  Alice Tseng; Jason Seet; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 9.  Therapeutic drug monitoring by dried blood spot: progress to date and future directions.

Authors:  Abraham J Wilhelm; Jeroen C G den Burger; Eleonora L Swart
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

10.  Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.

Authors:  Ute Blassmann; Anka C Roehr; Otto R Frey; Andreas Koeberer; Josef Briegel; Volker Huge; Cornelia Vetter-Kerkhoff
Journal:  Pharmacology       Date:  2016-04-06       Impact factor: 2.547
View more
  7 in total

1.  Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics.

Authors:  Shuyu Lin; Wenzhuo Yu; Bo Wang; Yichao Zhao; Ke En; Jialun Zhu; Xuanbing Cheng; Crystal Zhou; Haisong Lin; Zhaoqing Wang; Hannaneh Hojaiji; Christopher Yeung; Carlos Milla; Ronald W Davis; Sam Emaminejad
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

2.  A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization.

Authors:  Slobodan M Janković
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

3.  Therapeutic drug monitoring in the era of precision medicine: opportunities!

Authors:  Serge Cremers; Nishan Guha; Brian Shine
Journal:  Br J Clin Pharmacol       Date:  2016-10       Impact factor: 4.335

4.  Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation.

Authors:  Van Lam Nguyen; Sangjin Ahn; Pham Quang Hoa; Nguyen Phuoc Long; Sangzin Ahn; Yong-Soon Cho; Jae-Gook Shin
Journal:  Healthc Inform Res       Date:  2022-04-30

Review 5.  Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.

Authors:  Vanessa P Gaspar; Sahar Ibrahim; René P Zahedi; Christoph H Borchers
Journal:  J Mass Spectrom       Date:  2021-11-04       Impact factor: 1.982

6.  An integrated device for fast and sensitive immunosuppressant detection.

Authors:  Sara Tombelli; Cosimo Trono; Simone Berneschi; Chiara Berrettoni; Ambra Giannetti; Romeo Bernini; Gianluca Persichetti; Genni Testa; Guillermo Orellana; Francesca Salis; Susanne Weber; Peter B Luppa; Giampiero Porro; Giovanna Quarto; Markus Schubert; Marcel Berner; Paulo P Freitas; Susana Cardoso; Fernando Franco; Vânia Silverio; Maria Lopez-Martinez; Urs Hilbig; Kathrin Freudenberger; Günter Gauglitz; Holger Becker; Claudia Gärtner; Mark T O'Connell; Francesco Baldini
Journal:  Anal Bioanal Chem       Date:  2021-12-22       Impact factor: 4.142

Review 7.  The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.

Authors:  Thierry Buclin; Yann Thoma; Nicolas Widmer; Pascal André; Monia Guidi; Chantal Csajka; Laurent A Decosterd
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.